Skip to main content

Advertisement

Log in

In vitro characterisation of the anti-intravasative properties of the marine product heteronemin

  • Biologicals
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Metastases destroy the function of infested organs and are the main reason of cancer-related mortality. Heteronemin, a natural product derived from a marine sponge, was tested in vitro regarding its properties to prevent tumour cell intravasation through the lymph-endothelial barrier. In three-dimensional (3D) cell cultures consisting of MCF-7 breast cancer cell spheroids that were placed on lymph-endothelial cell (LEC) monolayers, tumour cell spheroids induce “circular chemorepellent-induced defects” (CCIDs) in the LEC monolayer; 12(S)-Hydroxyeicosatetraenoic acid (12(S)-HETE) and NF-κB activity are major factors inducing CCIDs, which are entry gates for tumour emboli intravasating the vasculature. This 3D co-culture is a validated model for the investigation of intravasation mechanisms and of drugs preventing CCID formation and hence lymph node metastasis. Furthermore, Western blot analyses, NF-κB reporter, EROD, SELE, 12(S)-HETE, and adhesion assays were performed to investigate the properties of heteronemin. Five micromolar heteronemin inhibited the directional movement of LECs and, therefore, the formation of CCIDs, which were induced by MCF-7 spheroids. Furthermore, heteronemin reduced the adhesion of MCF-7 cells to LECs and suppressed 12(S)-HETE-induced expression of the EMT marker paxillin, which is a regulator of directional cell migration. The activity of CYP1A1, which contributed to CCID formation, was also inhibited by heteronemin. Hence, heteronemin inhibits important mechanisms contributing to tumour intravasation in vitro and should be tested in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ALOX:

Lipoxygenase A

CCIDs:

Circular chemorepellent-induced defects

CYP:

Cytochrome P450

EMT:

Epithelial to mesenchymal transition

EROD:

Ethoxyresorufin-O-deethylase

HUVEC:

Human umbilical vein endothelial cell

ICAM-1:

Intercellular adhesion molecule 1

LEC:

Lymph-endothelial cell

MCL2:

Myosin light chain 2

SELE:

Selectin E

12(S)-HETE 12(S):

Hydroxyeicosatetraenoic acid

References

  • Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC (2009) Breast cancer. Clinical practice guidelines in oncology. NCCN Breast cancer clinical practice guidelines panel. J Natl Compr Canc Netw 7(2):122–192

    PubMed  CAS  Google Scholar 

  • Cragg GM, Newman DJ, Yang SS (2006) Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod 69(3):488–498

    Article  PubMed  CAS  Google Scholar 

  • Deakin NO, Turner CE (2008) Paxillin comes of age. J Cell Sci 121(15):2435–2444

    Article  PubMed  CAS  Google Scholar 

  • Digman MA, Brown CM, Horwitz AM, Mantulin WW, Gratton E (2008) Paxillin dynamics measured during adhesion assembly and disassembly by correlation spectroscopy. Biophys J 94(7):2819–2831

    Article  PubMed  CAS  Google Scholar 

  • Feng J, Masaaki I, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T (1999) Inhibitory phosphorylation site for rho-associated kinase on smooth muscle myosin phosphatase. J Cell Biol 274:37385–37390

    CAS  Google Scholar 

  • Folmer F, Jaspars M, Solano G, Cristofanon S, Henry E, Tabudravu J, Black K, Green DH, Küpper FC, Aalbersberg W, Feussner K, Dicato M, Diederich M (2009) The inhibition of TNF-α induced NF-κB activation by marine natural products. Biochem Pharmacol 78:592–606

    Article  PubMed  CAS  Google Scholar 

  • Giessrigl B, Yazici G, Teichmann M, Kopf S, Ghassemi S, Atanasov AG, Dirsch VM, Grusch M, Jäger W, Özmen A, Krupitza G (2012) Effects of scrophularia extracts on tumor cell proliferation, death and intravasation through lymphendothelial cell barriers. Int J Oncol 40(6):2063–2074

    PubMed  Google Scholar 

  • Gridling M, Stark N, Madlener S, Lackner A, Popescu R, Benedek B, Diaz R, Tut FM, Vo NTP, Huber D, Gollinger M, Saiko P, Özmen A, Mosgoeller W, de Martin R, Eytner R, Wagner KH, Grusch M, Fritzer-Szekeres M, Szekeres T, Kopp B, Frisch R, Krupitza G (2009) In vitro anti-cancer activity of two ethno-pharmacological healing plants from Guatemala Pluchea odorata and Phlebodium decumanum. Int J Oncol 34(4):1117–1128

    PubMed  Google Scholar 

  • Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C, Fuhrmann G, Kassie F, Steinkellner H, Smid K, Peters GJ, Jayaram H, Klepal T, Szekeres T, Knasmüller S, Krupitza G (2002) Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ 9:169–178

    Article  PubMed  CAS  Google Scholar 

  • Honn KV, Tang DG, Grossi I, Duniec ZM, Timar J, Renaud C, Leithauser M, Blair I, Johnson CR, Diglio CA et al (1994) Tumour cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res 54:565–574

    PubMed  CAS  Google Scholar 

  • Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K (2003) JNK phosphorylates paxillin and regulates cell migration. Nature 424:219–223

    Article  PubMed  CAS  Google Scholar 

  • Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, Card JW, Wang J, Zeldin DC, Wang DW (2007) Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res 67(14):6665–6674

    Article  PubMed  CAS  Google Scholar 

  • Jianxin AY, Deakin NO, Turner CE (2009) Paxillin-kinase-linker tyrosine phosphorylation regulates directional cell migration. Mol Biol Cell 20(22):4706–4719

    Article  Google Scholar 

  • Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, Keller T, Nagy-Bojarszky K, Huttary N, Raab I, Lackner K, Krautgasser K, Schachner H, Kaserer K, Rezar S, Madlener S, Vonach C, Davidovits A, Nosaka H, Hämmerle M, Viola K, Dolznig H, Schreiber M, Nader A, Mikulits W, Gnant M, Hirakawa S, Detmar M, Alitalo K, Nijman S, Offner F, Maier TJ, Steinhilber D, Krupitza G (2011) Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest 121(5):2000–2012

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi M, Okamoto T, Hayashi K, Yokoyama N, Sasaki T, Kitagawa I (1994) Marine natural products. XXXII. Absolute configurations of C-4 of the manoalide family, biologically active sesterterpenes from the marine sponge Hyrtios erecta. Chem Pharm Bull (Tokyo) 42(2):265–270

    Article  CAS  Google Scholar 

  • Kretschy N, Teichmann M, Kopf S, Atanasov AG, Saiko P, Vonach C, Viola K, Giessrig B, Huttary N, Raab I, Krieger S, Jäger W, Szekeres T, Nijman SM, Mikulits W, Dirsch VM, Dolznig H, Grusch M, Krupitza G (2013) In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipine and proadifen. Br J Cancer 108(3):570–578

    Article  PubMed  CAS  Google Scholar 

  • Leung HWC, Yang WH, Lai MY, Lin CJ, Lee HZ (2007) Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 45:403–411

    Article  PubMed  CAS  Google Scholar 

  • Lu H, Murtagh J, Schwartz EL (2006) The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (taxotere). Mol Pharmacol 69(4):1207–1215

    Article  PubMed  CAS  Google Scholar 

  • Madlener S, Svacinová J, Kitner M, Kopecky J, Eytner R, Lackner A, Vo NTP, Frisch R, Grusch M, de Martin R, Dolezal K, Strnad M, Krupitza G (2009) In vitro anti-inflammatory and anticancer activities of extracts of Acalypha alopecuroidea (Euphorbiaceae). Int J Oncol 35(4):881–891

    PubMed  Google Scholar 

  • Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, Krupitza G (2010) Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 102(9):1361–1370

    Article  PubMed  CAS  Google Scholar 

  • Nie D, Honn KV (2004) Eicosanoid regulation of angiogenesis in tumors. Semin Thromb Hemost 30:119–125

    Article  PubMed  CAS  Google Scholar 

  • Nie D, Nemeth J, Qiao Y, Zacharek A, Li L, Hanna K, Tang K, Hillman GG, Cher ML, Grignon DJ, Honn KV (2003) Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metast 20:657–663

    Article  CAS  Google Scholar 

  • Orlowski RZ, Baldwin AS Jr (2002) NF-κB as a therapeutic target in cancer. Trends Mol Med 8(8):385–389

    Article  PubMed  CAS  Google Scholar 

  • Paulitschke V, Schicher N, Szekeres T, Jäger W, Elbling L, Riemer AB, Scheiner O, Trimurtulu G, Venkateswarlu S, Mikula M, Swoboda A, Fiebiger E, Gerner C, Pehamberger H, Kunstfeld R (2010) 3,3′,4,4′,5,5′-Hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. J Invest Derm 130(6):1668–1679

    Article  PubMed  CAS  Google Scholar 

  • Rice RL, Tang DG, Hddadi M, Honn KV, Taylor JD (1998) 12(S)-Hydroxyeicosatetraenoic acid increases microfilament content in B16a melanoma cells: a protein kinase-dependent process. Int J Cancer 77:271–278

    Article  PubMed  CAS  Google Scholar 

  • Schoppmann SF, Soleiman A, Kalt R, Okubo Y, Benisch C, Nagavarapu U, Herron GS, Geleff S (2004) Telomerase-immortalized lymphatic and blood endothelial cells are functionally stable and retain their lineage specificity. Microcirculation 11:261–269

    Article  PubMed  CAS  Google Scholar 

  • Schumacher M, Cerella C, Eifes S, Chateauvieux S, Morceau F, Jaspars M, Dicato M, and Diederich M (2010) Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death. Biochem Pharmacol 79(4):610–622 Epub. Erratum in: Biochem Pharmacol 2010 79(12):1837

    Google Scholar 

  • Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) TNM classification of malignant tumours (Uicc International Union Against Cancer). Wiley-Blackwell, New York

    Google Scholar 

  • Spector AA, Gordon JA, Moore SA (1988) Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res 27:271–323

    Article  PubMed  CAS  Google Scholar 

  • Tang DG, Timar J, Grossi IM, Renaud C, Kimler VA, Diglio CA, Taylor JD, Honn KV (1993) The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res 207:361–375

    Article  PubMed  CAS  Google Scholar 

  • Uchide K, Sakon M, Ariyoshi H, Nakamori S, Tokunaga M, Monden M (2007) Cancer cells cause vascular endothelial cell retraction via 12(S)-HETE secretion; the possible role of cancer cell derived microparticle. Ann Surg Oncol 14:862–868

    Article  PubMed  Google Scholar 

  • van Zijl F, Krupitza G, Mikulits W (2011) Initial steps of metastasis: cell invasion and endothelial transmigration. Rev Mutat Res 728(1–2):23–34

    Article  Google Scholar 

  • Viola K, Kopf S, Huttary N, Vonach C, Kretschy N, Teichmann M, Giessrigl B, Raab I, Stary S, Krieger S, Keller T, Bauer S, Hantusch B, Szekeres T, de Martin R, Jäger W, Mikulits W, Dolznig H, Krupitza G, Grusch M (2013a) Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion. Br J Cancer 108(3):564–569

    Article  PubMed  CAS  Google Scholar 

  • Viola K, Kopf S, Rarova L, Jarukamjorn K, Kretschy N, Teichmann M, Vonach C, Atanasov AG, Giessrigl B, Huttary N, Raab I, Krieger S, Strnad M, de Martin R, Saiko P, Szekeres T, Knasmüller S, Dirsch VM, Jäger W, Grusch M, Dolznig H, Mikulits W, Krupitza G (2013b) Xanthohumol attenuates tumor cell-mediated breaching of the lymphoendothelial barrier and prevents intravasation and metastasis. Arch Toxicol [Epub ahead of print]

  • Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Kalt R, Krieger S, Vo NTP, Madlener S, Bauer S, Marian B, Hämmerle M, Kretschy N, Teichmann M, Hantusch B, Stary S, Unger C, Seelinger M, Eger A, Mader R, Jäger W, Schmidt W, Grusch M, Dolznig H, Mikulits W, Krupitza G (2011) NF-κB mediates the12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br J Cancer 105(2):263–271

    Article  PubMed  CAS  Google Scholar 

  • West KA, Zhang H, Brown MC, Nikolopoulos SN, Riedy MC, Horwitz AF, Turner CE (2001) The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol 154(1):161–176

    Article  PubMed  CAS  Google Scholar 

  • Wonganuchitmeta SN, Yuenyongsawad S, Keawpradub N, Plubrukarn A (2004) Antitubercular sesterterpenes from the Thai sponge Brachiaster sp. J Nat Prod 7(10):1767–1770

    Article  Google Scholar 

  • Yoshimura R, Matsuyama M, Mitsuhashi M, Takemoto Y, Tsuchida K, Kawahito Y, Sano H, Nakatani T (2004) Relationship between lipoxygenase and human testicular cancer. Int J Mol Med 13:389–393

    PubMed  CAS  Google Scholar 

  • Zhang JS, Nelson M, Wang L, Liu W, Qian CP, Shridhar V, Urrutia R, Smith DI (1998) Identification and chromosomal localization of CTNNAL1, a novel protein homologous to alpha-catenin. Genomics 54:149–154

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We wish to thank Toni Jäger for preparing the figures and to Prof Ulrichova for kindly providing HUVEC cells. Heteronemin was a kind gift of Professor Marcel Jaspars (University of Aberdeen) and was originally obtained from the NCI open repository. This work was supported by the Austrian Science Fund, FWF, grant number P20905-B13 (to W.M.), and grant numbers S10704-B03 and S10704-B13 (to V.M.D.), by the European Union, FP7 Health Research, project number HEALTH-F4-2008-202047 (to W.M.), further by a grant of the Fellinger foundation (to G.K.), grants of the Herzfelder family foundation (to T.S., H.D., P.S. and M.G.), a grant of the “Hochschuljubilaeumsstiftung der Stadt Wien” grant number H-2498/2011 (to P.S.), a scholarship from the Austrian exchange service OeAD (to K.J.). Grant Agency of the Czech Republic GACR (P505/11/1163) and ED0007/01/01 (to L.R. and M.S) from the Centre of the Region Haná for Biotechnological and Agricultural Research is also gratefully acknowledged.

Conflict of interests

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georg Krupitza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kopf, S., Viola, K., Atanasov, A.G. et al. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin. Arch Toxicol 87, 1851–1861 (2013). https://doi.org/10.1007/s00204-013-1045-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-013-1045-1

Keywords

Navigation